SERUM HORMONE LEVELS IN MEN WITH END STAGE RENAL-DISEASE

被引:13
|
作者
CARLSTROM, K
POUSETTE, A
STEGE, R
LINDHOLM, A
机构
[1] HUDDINGE UNIV HOSP,KAROLINSKA INST,DEPT CLIN CHEM,S-14186 HUDDINGE,SWEDEN
[2] HUDDINGE UNIV HOSP,KAROLINSKA INST,DEPT UROL,S-14186 HUDDINGE,SWEDEN
[3] HUDDINGE UNIV HOSP,KAROLINSKA INST,DEPT CLIN PHARMACOL,S-14186 HUDDINGE,SWEDEN
来源
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY | 1990年 / 24卷 / 01期
关键词
Adrenal androgens; Cortisol; End stage renal disease; Estrogens; Steroid conjugates;
D O I
10.3109/00365599009180364
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Serum concentrations of testicular and adrenal androgens and androgen precursors, Cortisol, unconjugated (E1) and total estrone (tE1; >85% E1 sulfate). pituitary hormones, sex hormone binding globulin (SHBG) and albumin were measured in 14 male patients with nondiabetic end stage renal disease and in 28 age-matched healthy controls, The serum levels of the adrenal androgens 4-androstene 3,17-dione and dehydroepiandroster-one (DHA) were significantly lower and the levels of cortisol, LH, prolactin and tE1 significantly higher in the patients than in the controls. The ratios between E1 and tE1 and between DHA and DHA sulfate were strongly decreased in the patients, The findings are suggested to reflect different effects of the disease upon the metabolism of cortisol and of adrenal androgens and also the reduced or even absent urinary excretion. leading to a decreased metabolism of steroid conjugates. © 1990 Informa UK Ltd.
引用
收藏
页码:75 / 78
页数:4
相关论文
共 50 条
  • [21] CHANGING PATTERNS OF END-STAGE RENAL-DISEASE DUE TO HYPERTENSION
    QUALHEIM, RE
    ROSTAND, SG
    KIRK, KA
    RUTSKY, EA
    LUKE, RG
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (03) : 336 - 343
  • [22] CLINICAL DOCUMENTATION OF END-STAGE RENAL-DISEASE DUE TO HYPERTENSION
    SCHLESSINGER, SD
    TANKERSLEY, MR
    CURTIS, JJ
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (05) : 655 - 660
  • [23] PHARMACOKINETICS OF TORASEMIDE AND ITS METABOLITES IN END-STAGE RENAL-DISEASE
    KRAMER, BK
    SCHWAB, A
    BRAUN, N
    STRUTZ, F
    MULLER, GA
    RISLER, T
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 47 (02) : 157 - 159
  • [24] TREATMENT OF BLADDER DYSFUNCTION IN CHILDREN WITH END-STAGE RENAL-DISEASE
    BURNS, MW
    WATKINS, SL
    MITCHELL, ME
    TAPPER, D
    JOURNAL OF PEDIATRIC SURGERY, 1992, 27 (02) : 170 - 174
  • [26] QUALITY-OF-LIFE ASSESSMENT IN END-STAGE RENAL-DISEASE
    KOOTSTRA, G
    THEORETICAL SURGERY, 1992, 7 (01): : 24 - 26
  • [27] THE MANAGEMENT OF END-STAGE RENAL-DISEASE IN INFANTS WITH IMPERFORATE ANUS
    SHARMA, AK
    KASHTAN, CE
    NEVINS, TE
    PEDIATRIC NEPHROLOGY, 1993, 7 (06) : 721 - 724
  • [28] Effect of fluvastatin on serum prohepcidin levels in patients with end-stage renal disease
    Arabul, Mahnnut
    Gullulu, Mustafa
    Yilmaz, Yusuf
    Akdag, Ibrahim
    Kahvecioglu, Serdar
    Eren, Mehmet Ali
    Dilek, Kamil
    CLINICAL BIOCHEMISTRY, 2008, 41 (13) : 1055 - 1058
  • [29] RESIDENTIAL SUMMER CAMP FOR CHILDREN WITH END-STAGE RENAL-DISEASE
    WARADY, BA
    CARR, B
    HELLERSTEIN, S
    ALON, U
    CHILD NEPHROLOGY AND UROLOGY, 1992, 12 (04) : 212 - 215
  • [30] DILTIAZEM ENHANCES POTASSIUM DISPOSAL IN SUBJECTS WITH END-STAGE RENAL-DISEASE
    SOLOMON, R
    DUBEY, A
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (05) : 420 - 426